S Fahn, G Craddock, G Kumin. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Acute DiseaseAmantadine/administration & dosageAmantadine/metabolismAmantadine/pharmacologyAmantadine/poisoningBlood-Brain BarrierChlorpromazine/therapeutic useHumansMaleMiddle AgedParkinson Disease, Postencephalitic/drug therapyParkinson Disease, Postencephalitic/metabolismPhenytoin/therapeutic usePsychoses, Substance-Induced/drug therapyPsychoses, Substance-Induced/etiologySuicideSympathetic Nervous System/drug effects
Substances: See more » PhenytoinAmantadineChlorpromazine
Year: 1971 PMID: 5146411 DOI: 10.1001/archneur.1971.00490010055008
Source DB: PubMed Journal: Arch Neurol ISSN: 0003-9942